Ablation of the posterior nasal nerve using the NEUROMARK system led to greater reductions in nasal symptoms and improvements ...
TUESDAY, Dec. 30, 2025 (HealthDay News) -- The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and ...
The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study ...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Allergic Rhinitis pipeline constitutes 35+ key companies continuously working towards developing 35+ Allergic Rhinitis ...
The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...
Rhinitis, a prevalent inflammatory condition of the upper airway, imposes a substantial global health burden. While current pharmacotherapies alleviate symptoms, they are ineffective in restoring ...
"These long-term results provide robust evidence that NEUROMARK offers durable relief for patients suffering from chronic rhinitis, addressing not only nasal symptoms but also postnasal drip, cough, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback